Skip to main navigation menu Skip to main content Skip to site footer

Admin menu

Volume 7 (2020): Issue 1

Improving haemophilia diagnosis in developing countries: the Malian experience

Abstract

Abstract Introduction

Around 90% of all undiagnosed people with haemophilia (PWH) live in developing countries. In Mali, in sub-Saharan Africa, nearly 90% of potential PWH are not identified. We initiated a two-year study involving an integrated programme of training and awareness-raising with the aim of improving diagnosis and access to care for PWH, based on partnership with those who regularly interact with them.

Methodology

Our training programme focused on four regions of Mali and the district of Bamako, and included three types of health professionals from different districts and hospitals: medical doctor, nurse and laboratory technician. We also targeted traditional healers, who continue to be strongly involved in local healthcare, and provided training sessions for patients and their families on the symptoms, diagnosis, treatment and complications of haemophilia. A complementary programme of awareness-raising, including the national media, ran alongside the training sessions.

Results

Overall, the programme involved 495 participants: 213 health care professionals, 24 patients, 79 parents of patients, 126 traditional healers, and 53 media workers. A direct result was development of collaboration between these groups in identifying haemophilia, and the transfer of four patients from a traditional healer's office to hospital for diagnosis and treatment. The number of diagnosed PWH increased from 42 in 2016 to 126 in 2017.

Conclusion

The integrated haemophilia educational programme, which took into account the nature of the local environment and involved all relevant stakeholders, showed that taking a collaborative approach is a successful strategy for improving diagnosis and care for PWH in Mali. This approach could be relevant in other developing countries.

Article

View Full Article

References

  • 1. Iorio A, Stonebraker JS, Chambost H, et al.; Data and Demographics Committee of the World Federation of Hemophilia. Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries. Ann Intern Med 2019 Sep 10. doi: https://doi.org/10.7326/M19–1208.
  • 2. O’Mahony B, Black C. Expanding haemophilia care in developing countries. Semin Thromb Hemost 2005; 31(5): 561–8.
  • 3. Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe haemophilia. N Engl J Med 2007; 357: 535–44. doi: https://doi.org/10.1056/NEJMoa067659.
  • 4. Ferreira AA, Bustamante-Teixiera MT, Gonçalves Leite IC, et al. Clinical and functional evaluation of the joint status of haemophiliac adults at a Brazilian blood center. Rev Bras Hematol Hemoter 2013; 35(1): 23–8. doi: https://doi.org/10.5581/1516-8484.20130010.
  • 5. van den Berg HM, Fischer K, Mauser-Bunschoten EP, et al. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol 2001; 112(3): 561–5. doi: https://doi.org/10.1046/j.1365-2141.2001.02580.x.
  • 6. Gouider E, Jouini L, Achour M, et al. Low dose prophylaxis in Tunisian children with haemophilia. Haemophilia 2017; 23(1): 77–81. doi: https://doi.org/10.1111/hae.13048.
  • 7. Giangrande PL, Black C. World Federation of Haemophilia programs in developing countries. Semin Thromb Hemost 2005; 31(5): 555–60. doi: https://doi.org/10.1055/s-2005-922227.
  • 8. World Federation of Haemophilia. Report on the Annual Global Survey 2016. Available from https://www1.wfh.org/publications/files/pdf-1690.pdf (accessed 14 April 2020).
  • 9. Beyan C, Kaptan K, Ifran A. Hemophilic arthropathy in non-severe haemophiliacs. Rheumatol Int 2007; 27(5): 501–2. doi: https://doi.org/10.1007/s00296-006-0246-9.
  • 10. Gurcay E, Eksioglu E, Ezer U, Tuncay R, Cakci A. Functional disability in children with hemophilic arthropathy. Rheumatol Int 2006; 26(11): 1031–5. doi: https://doi.org/10.1007/s00296-006-0115-6.
  • 11. Monahan PE, Doria AS, Ljung R, Jiménez-Yuste V. Optimizing joint function: new knowledge and novel tools and treatments. Haemophilia 2012; 18 Suppl 5: 17–26. doi: https://doi.org/10.1111/j.1365-2516.2012.02888.x.
  • 12. Diop S, Seck M, Sy-Bah D, et al. Implementing haemophilia care in Senegal, West Africa. Haemophilia (2014), 20, 73–77. doi: https://doi.org/10.1111/hae.12249.
  • 13. Antunes SV. Haemophilia in the developing world: the Brazilian experience. Haemophilia (2002), 8, 199–204. doi: https://doi.org/10.1046/j.1365-2516.2002.00638.x.
  • 14. Isarangkura P. Haemophilia care in the developing world: benchmarking for excellence. Haemophilia (2002), 8, 205–210. doi: https://doi.org/10.1046/j.1365-2516.2002.00600.x.
  • 15. Donnelly J. Patient Outreach Guide for Hemophilia and Other Bleeding Disorders. World Federation of Hemophilia. World Federation of Hemophilia, 2008. Available from http://www1.wfh.org/publications/files/pdf-1401.pdf (accessed 14 April 2020).
  • 16. Sanogo R. Medicinal plants traditionally used in Mali for dysmenorrhea. Afr J Tradit Complement Altern Med 2011; 8(5 Suppl): 90–6. doi: https://doi.org/10.4314/ajtcam.v8i5S.4.
  • 17. Gabriel Weimann DHT, van Vuuren D, Jouber JPR. Looking for opinion leaders: traditional vs. modern measures in traditional societies. International Journal of Public Opinion Research 2007; 19(2): 173–90. doi: https://doi.org/10.1093/ijpor/edm005.
  • 18. Kolawole A. Analysis of the influence of opinion leaders on voting decision of rural voters: an evidence from Ayetoro, Ogun-State of Nigeria. IOSR Journal of Humanities and Social Science 2016; 21(1): 46–53. doi: https://doi.org/10.9790/0837-21134653.

PDF Download

Download PDF

Open in full-page viewer

Authors

  • YL Diallo

    ORCID iD
    yldialloml@gmail.com
    Department of Medicine, Hôpital du Mali, Bamako, Mali
  • A Poudiougo

    ORCID iD
    Laboratory Department, Gabriel Touré University Hospital, Bamako, Mali
  • BSI Drame

    ORCID iD
    Laboratory Department, Hôpital du Mali, Bamako, Mali
  • AS Traore

    ORCID iD
    Department of Medicine, Hôpital Somino Dolo, Sevare, Mali
  • Y Cissoko

    ORCID iD
    Department of Tropical Infectious Diseases, Point G Teaching Hospital, Bamako, Mali
  • M Doumbere

    ORCID iD
    Department of Medicine, Hôpital du Mali, Bamako, Mali
  • H Kone

    ORCID iD
    Laboratory Department, Hôpital du Mali, Bamako, Mali
  • Z Sountoura

    ORCID iD
    Department of Medicine, Hôpital du Mali, Bamako, Mali
  • AA Diakite

    ORCID iD
    Department of Paediatrics, Gabriel Touré University Hospital, Bamako, Mali
  • AT Sidibe

    ORCID iD
    Department of Medicine, Hôpital du Mali, Bamako, Mali
  • JF Schved

    ORCID iD
    Haemophilia Treatment Centre, University Hospital, Montpellier, France